Innovative Product — “SAPIEN 3 TAVR” is Approved by NMPA
On June 8, 2020, NMPA approved the registration of an innovative device — “SAPIEN 3 TAVR” made by Edwards Lifesciences LLC. The product is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be appropriate for the transcatheter heart valve replacement therapy.
